Florida Senate - 2026 SB 432
By Senator Yarborough
4-00311B-26 2026432__
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; adding 7-Hydroxymitragynine as a
4 Schedule I controlled substance; excepting from the
5 list of Schedule I controlled substances certain
6 xylazine animal drug products approved by the United
7 States Food and Drug Administration and used for
8 certain purposes; amending s. 893.13, F.S.; providing
9 criminal penalties and requiring a mandatory minimum
10 term of imprisonment if a person sells, manufactures,
11 or delivers or possesses with intent to sell,
12 manufacture, or deliver xylazine; amending s. 893.135,
13 F.S.; creating the offense of trafficking in xylazine;
14 providing criminal penalties and requiring a mandatory
15 minimum term of imprisonment and fines based on the
16 quantity of the controlled substance involved in the
17 offense; providing effective dates.
18
19 Be It Enacted by the Legislature of the State of Florida:
20
21 Section 1. Effective July 1, 2026, paragraphs (a) and (c)
22 of subsection (1) of section 893.03, Florida Statutes, are
23 amended to read:
24 893.03 Standards and schedules.—The substances enumerated
25 in this section are controlled by this chapter. The controlled
26 substances listed or to be listed in Schedules I, II, III, IV,
27 and V are included by whatever official, common, usual,
28 chemical, trade name, or class designated. The provisions of
29 this section shall not be construed to include within any of the
30 schedules contained in this section any excluded drugs listed
31 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
32 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
33 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
34 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
35 Anabolic Steroid Products.”
36 (1) SCHEDULE I.—A substance in Schedule I has a high
37 potential for abuse and has no currently accepted medical use in
38 treatment in the United States and in its use under medical
39 supervision does not meet accepted safety standards. The
40 following substances are controlled in Schedule I:
41 (a) Unless specifically excepted or unless listed in
42 another schedule, any of the following substances, including
43 their isomers, esters, ethers, salts, and salts of isomers,
44 esters, and ethers, whenever the existence of such isomers,
45 esters, ethers, and salts is possible within the specific
46 chemical designation:
47 1. Acetyl-alpha-methylfentanyl.
48 2. Acetylmethadol.
49 3. Allylprodine.
50 4. Alphacetylmethadol (except levo-alphacetylmethadol, also
51 known as levo-alpha-acetylmethadol, levomethadyl acetate, or
52 LAAM).
53 5. Alphamethadol.
54 6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
55 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
56 (N-propanilido) piperidine).
57 7. Alpha-methylthiofentanyl.
58 8. Alphameprodine.
59 9. Benzethidine.
60 10. Benzylfentanyl.
61 11. Betacetylmethadol.
62 12. Beta-hydroxyfentanyl.
63 13. Beta-hydroxy-3-methylfentanyl.
64 14. Betameprodine.
65 15. Betamethadol.
66 16. Betaprodine.
67 17. Clonitazene.
68 18. Dextromoramide.
69 19. Diampromide.
70 20. Diethylthiambutene.
71 21. Difenoxin.
72 22. Dimenoxadol.
73 23. Dimepheptanol.
74 24. Dimethylthiambutene.
75 25. Dioxaphetyl butyrate.
76 26. Dipipanone.
77 27. Ethylmethylthiambutene.
78 28. Etonitazene.
79 29. Etoxeridine.
80 30. Flunitrazepam.
81 31. Furethidine.
82 32. Hydroxypethidine.
83 33. Ketobemidone.
84 34. Levomoramide.
85 35. Levophenacylmorphan.
86 36. Desmethylprodine (1-Methyl-4-Phenyl-4
87 Propionoxypiperidine).
88 37. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
89 piperidyl]-N-phenylpropanamide).
90 38. 3-Methylthiofentanyl.
91 39. Morpheridine.
92 40. Noracymethadol.
93 41. Norlevorphanol.
94 42. Normethadone.
95 43. Norpipanone.
96 44. Para-Fluorofentanyl.
97 45. Phenadoxone.
98 46. Phenampromide.
99 47. Phenomorphan.
100 48. Phenoperidine.
101 49. PEPAP (1-(2-Phenylethyl)-4-Phenyl-4
102 Acetyloxypiperidine).
103 50. Piritramide.
104 51. Proheptazine.
105 52. Properidine.
106 53. Propiram.
107 54. Racemoramide.
108 55. Thenylfentanyl.
109 56. Thiofentanyl.
110 57. Tianeptine.
111 58. Tilidine.
112 59. Trimeperidine.
113 60. Acetylfentanyl.
114 61. Butyrylfentanyl.
115 62. Beta-Hydroxythiofentanyl.
116 63. Fentanyl derivatives. Unless specifically excepted,
117 listed in another schedule, or contained within a pharmaceutical
118 product approved by the United States Food and Drug
119 Administration, any material, compound, mixture, or preparation,
120 including its salts, isomers, esters, or ethers, and salts of
121 isomers, esters, or ethers, whenever the existence of such salts
122 is possible within any of the following specific chemical
123 designations containing a 4-anilidopiperidine structure:
124 a. With or without substitution at the carbonyl of the
125 aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl,
126 methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl,
127 dihydrofuranyl, benzyl moiety, or rings containing heteroatoms
128 sulfur, oxygen, or nitrogen;
129 b. With or without substitution at the piperidine amino
130 moiety with a phenethyl, benzyl, alkylaryl (including
131 heteroaromatics), alkyltetrazolyl ring, or an alkyl or
132 carbomethoxy group, whether or not further substituted in the
133 ring or group;
134 c. With or without substitution or addition to the
135 piperdine ring to any extent with one or more methyl,
136 carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester
137 groups;
138 d. With or without substitution of one or more hydrogen
139 atoms for halogens, or methyl, alkyl, or methoxy groups, in the
140 aromatic ring of the anilide moiety;
141 e. With or without substitution at the alpha or beta
142 position of the piperidine ring with alkyl, hydroxyl, or methoxy
143 groups;
144 f. With or without substitution of the benzene ring of the
145 anilide moiety for an aromatic heterocycle; and
146 g. With or without substitution of the piperidine ring for
147 a pyrrolidine ring, perhydroazepine ring, or azepine ring;
148
149 excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil;
150 including, but not limited to:
151 (I) Acetyl-alpha-methylfentanyl.
152 (II) Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
153 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
154 (N-propanilido) piperidine).
155 (III) Alpha-methylthiofentanyl.
156 (IV) Benzylfentanyl.
157 (V) Beta-hydroxyfentanyl.
158 (VI) Beta-hydroxy-3-methylfentanyl.
159 (VII) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
160 piperidyl]-N-phenylpropanamide).
161 (VIII) 3-Methylthiofentanyl.
162 (IX) Para-Fluorofentanyl.
163 (X) Thenylfentanyl or Thienyl fentanyl.
164 (XI) Thiofentanyl.
165 (XII) Acetylfentanyl.
166 (XIII) Butyrylfentanyl.
167 (XIV) Beta-Hydroxythiofentanyl.
168 (XV) Lofentanil.
169 (XVI) Ocfentanil.
170 (XVII) Ohmfentanyl.
171 (XVIII) Benzodioxolefentanyl.
172 (XIX) Furanyl fentanyl.
173 (XX) Pentanoyl fentanyl.
174 (XXI) Cyclopentyl fentanyl.
175 (XXII) Isobutyryl fentanyl.
176 (XXIII) Remifentanil.
177 64. Nitazene derivatives. Unless specifically excepted,
178 listed in another schedule, or contained within a pharmaceutical
179 product approved by the United States Food and Drug
180 Administration, any material, compound, mixture, or preparation,
181 including its salts, isomers, esters, or ethers, and salts of
182 isomers, esters, or ethers, whenever the existence of such salts
183 is possible within any of the following specific chemical
184 designations containing a benzimidazole ring with an ethylamine
185 substitution at the 1-position and a benzyl ring substitution at
186 the 2-position structure:
187 a. With or without substitution on the benzimidazole ring
188 with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups,
189 or halogens;
190 b. With or without substitution at the ethylamine amino
191 moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or
192 not further substituted in the ring system;
193 c. With or without inclusion of the ethylamine amino moiety
194 in a cyclic structure;
195 d. With or without substitution of the benzyl ring; or
196 e. With or without replacement of the benzyl ring with an
197 aromatic ring, including, but not limited to:
198 (I) Butonitazene.
199 (II) Clonitazene.
200 (III) Etodesnitazene.
201 (IV) Etonitazene.
202 (V) Flunitazene.
203 (VI) Isotodesnitazene.
204 (VII) Isotonitazene.
205 (VIII) Metodesnitazene.
206 (IX) Metonitazene.
207 (X) Nitazene.
208 (XI) N-Desethyl Etonitazene.
209 (XII) N-Desethyl Isotonitazene.
210 (XIII) N-Piperidino Etonitazene.
211 (XIV) N-Pyrrolidino Etonitazene.
212 (XV) Protonitazene.
213 65. 7-Hydroxymitragynine (methyl (E)-2-[(2S,3S,7aS,12bS)-3
214 ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H
215 indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate)
216 concentrated at a level above 400 parts per million on a dry
217 weight basis.
218 (c) Unless specifically excepted or unless listed in
219 another schedule, any material, compound, mixture, or
220 preparation that contains any quantity of the following
221 hallucinogenic substances or that contains any of their salts,
222 isomers, including optical, positional, or geometric isomers,
223 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
224 salts of isomers, homologues, nitrogen-heterocyclic analogs,
225 esters, or ethers, if the existence of such salts, isomers, and
226 salts of isomers is possible within the specific chemical
227 designation or class description:
228 1. Alpha-Ethyltryptamine.
229 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
230 oxazoline).
231 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
232 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
233 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
234 6. Bufotenine.
235 7. Cannabis.
236 8. Cathinone.
237 9. DET (Diethyltryptamine).
238 10. 2,5-Dimethoxyamphetamine.
239 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
240 12. DMT (Dimethyltryptamine).
241 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
242 analog of phencyclidine).
243 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
244 15. N-Ethylamphetamine.
245 16. Fenethylline.
246 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
247 18. Ibogaine.
248 19. LSD (Lysergic acid diethylamide).
249 20. Mescaline.
250 21. Methcathinone.
251 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
252 23. PMA (4-Methoxyamphetamine).
253 24. PMMA (4-Methoxymethamphetamine).
254 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
255 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
256 27. MDA (3,4-Methylenedioxyamphetamine).
257 28. JB-336 (N-Methyl-3-piperidyl benzilate).
258 29. N,N-Dimethylamphetamine.
259 30. Parahexyl.
260 31. Peyote.
261 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
262 analog of phencyclidine).
263 33. Psilocybin.
264 34. Psilocyn.
265 35. Salvia divinorum, except for any drug product approved
266 by the United States Food and Drug Administration which contains
267 Salvia divinorum or its isomers, esters, ethers, salts, and
268 salts of isomers, esters, and ethers, if the existence of such
269 isomers, esters, ethers, and salts is possible within the
270 specific chemical designation.
271 36. Salvinorin A, except for any drug product approved by
272 the United States Food and Drug Administration which contains
273 Salvinorin A or its isomers, esters, ethers, salts, and salts of
274 isomers, esters, and ethers, if the existence of such isomers,
275 esters, ethers, and salts is possible within the specific
276 chemical designation.
277 37. Xylazine, except for a xylazine animal drug product
278 approved by the United States Food and Drug Administration and
279 the use of which conforms to the approved application or is
280 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
281 importation, distribution, prescribing, or sale of xylazine for
282 human use is not subject to this exception.
283 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
284 (Thiophene analog of phencyclidine).
285 39. 3,4,5-Trimethoxyamphetamine.
286 40. Methylone (3,4-Methylenedioxymethcathinone).
287 41. MDPV (3,4-Methylenedioxypyrovalerone).
288 42. Methylmethcathinone.
289 43. Methoxymethcathinone.
290 44. Fluoromethcathinone.
291 45. Methylethcathinone.
292 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
293 yl)phenol) and its dimethyloctyl (C8) homologue.
294 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
295 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
296 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
297 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
298 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
299 naphthoyl)indole).
300 51. BZP (Benzylpiperazine).
301 52. Fluorophenylpiperazine.
302 53. Methylphenylpiperazine.
303 54. Chlorophenylpiperazine.
304 55. Methoxyphenylpiperazine.
305 56. DBZP (1,4-Dibenzylpiperazine).
306 57. TFMPP (Trifluoromethylphenylpiperazine).
307 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
308 Methylenedioxy-N-methylbutanamine).
309 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
310 60. 5-Hydroxy-N-methyltryptamine.
311 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
312 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
313 63. Methyltryptamine.
314 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
315 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
316 66. Tyramine (4-Hydroxyphenethylamine).
317 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
318 68. DiPT (N,N-Diisopropyltryptamine).
319 69. DPT (N,N-Dipropyltryptamine).
320 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
321 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
322 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
323 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
324 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
325 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
326 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
327 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
328 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
329 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
330 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
331 81. Butylone (3,4-Methylenedioxy-alpha
332 methylaminobutyrophenone).
333 82. Ethcathinone.
334 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
335 84. Naphyrone (Naphthylpyrovalerone).
336 85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
337 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
338 87. 3,4-Methylenedioxy-propiophenone.
339 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
340 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
341 90. 3,4-Methylenedioxy-N-acetylcathinone.
342 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
343 92. 3,4-Methylenedioxy-N-acetylethcathinone.
344 93. Bromomethcathinone.
345 94. Buphedrone (alpha-Methylamino-butyrophenone).
346 95. Eutylone (3,4-Methylenedioxy-alpha
347 ethylaminobutyrophenone).
348 96. Dimethylcathinone.
349 97. Dimethylmethcathinone.
350 98. Pentylone (3,4-Methylenedioxy-alpha
351 methylaminovalerophenone).
352 99. MDPPP (3,4-Methylenedioxy-alpha
353 pyrrolidinopropiophenone).
354 100. MDPBP (3,4-Methylenedioxy-alpha
355 pyrrolidinobutyrophenone).
356 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
357 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
358 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
359 (Benocyclidine).
360 104. F-MABP (Fluoromethylaminobutyrophenone).
361 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
362 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
363 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
364 108. Me-EABP (Methylethylaminobutyrophenone).
365 109. Etizolam.
366 110. PPP (Pyrrolidinopropiophenone).
367 111. PBP (Pyrrolidinobutyrophenone).
368 112. PVP (Pyrrolidinovalerophenone) or
369 (Pyrrolidinopentiophenone).
370 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
371 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
372 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
373 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
374 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
375 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
376 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
377 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
378 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
379 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
380 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
381 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
382 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
383 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
384 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
385 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
386 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
387 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
388 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
389 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
390 ol).
391 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
392 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
393 methanol).
394 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
395 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
396 1,4-dione).
397 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
398 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
399 undecanamide).
400 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
401 undecanamide).
402 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
403 methyloctan-2-yl)phenol).
404 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
405 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
406 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
407 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
408 methoxyphenylacetyl)indole).
409 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
410 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
411 naphthalenylmethanone).
412 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
413 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
414 naphthalenylmethanone).
415 143. Pentedrone (alpha-Methylaminovalerophenone).
416 144. Fluoroamphetamine.
417 145. Fluoromethamphetamine.
418 146. Methoxetamine.
419 147. Methiopropamine.
420 148. Methylbuphedrone (Methyl-alpha
421 methylaminobutyrophenone).
422 149. APB ((2-Aminopropyl)benzofuran).
423 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
424 151. UR-144 (1-Pentyl-3-(2,2,3,3
425 tetramethylcyclopropanoyl)indole).
426 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
427 tetramethylcyclopropanoyl)indole).
428 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
429 tetramethylcyclopropanoyl)indole).
430 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
431 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
432 iodobenzoyl)indole).
433 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
434 carboxamide).
435 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
436 cyclohexylcarbamate).
437 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
438 cyclohexyl ester).
439 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
440 benzoxazin-4-one).
441 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
442 161. 2C-H (2,5-Dimethoxyphenethylamine).
443 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
444 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
445 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
446 methoxybenzyl)]phenethylamine).
447 165. MDMA (3,4-Methylenedioxymethamphetamine).
448 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
449 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
450 carboxylate).
451 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
452 carboxylate).
453 169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
454 3-carboxamide).
455 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
456 pentylindazole-3-carboxamide).
457 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
458 (4-fluorobenzyl)indazole-3-carboxamide).
459 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
460 1-pentylindazole-3-carboxamide).
461 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
462 yl)-1-(fluoropentyl)indole-3-carboxamide).
463 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
464 methoxybenzyl)]phenethylamine).
465 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
466 methoxybenzyl)]phenethylamine).
467 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
468 (cyclohexylmethyl)indazole-3-carboxamide).
469 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
470 carboxylate).
471 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
472 3-carboxamide).
473 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
474 (fluoropentyl)indazole-3-carboxamide).
475 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
476 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
477 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
478 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
479 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
480 hexahydrobenzo[c]chromen-1-ol).
481 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
482 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
483 hexahydrobenzo[c]chromen-1-ol).
484 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
485 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
486 diol).
487 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
488 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
489 tetrahydro-6aH-benzo[c]chromen-1-ol).
490 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
491 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
492 187. MAPB ((2-Methylaminopropyl)benzofuran).
493 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
494 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
495 190. Synthetic Cannabinoids.—Unless specifically excepted
496 or unless listed in another schedule or contained within a
497 pharmaceutical product approved by the United States Food and
498 Drug Administration, any material, compound, mixture, or
499 preparation that contains any quantity of a synthetic
500 cannabinoid found to be in any of the following chemical class
501 descriptions, or homologues, nitrogen-heterocyclic analogs,
502 isomers (including optical, positional, or geometric), esters,
503 ethers, salts, and salts of homologues, nitrogen-heterocyclic
504 analogs, isomers, esters, or ethers, whenever the existence of
505 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
506 ethers, salts, and salts of isomers, esters, or ethers is
507 possible within the specific chemical class or designation.
508 Since nomenclature of these synthetically produced cannabinoids
509 is not internationally standardized and may continually evolve,
510 these structures or the compounds of these structures shall be
511 included under this subparagraph, regardless of their specific
512 numerical designation of atomic positions covered, if it can be
513 determined through a recognized method of scientific testing or
514 analysis that the substance contains properties that fit within
515 one or more of the following categories:
516 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
517 naturally contained in a plant of the genus Cannabis, the
518 synthetic equivalents of the substances contained in the plant
519 or in the resinous extracts of the genus Cannabis, or synthetic
520 substances, derivatives, and their isomers with similar chemical
521 structure and pharmacological activity, including, but not
522 limited to, Delta 9 tetrahydrocannabinols and their optical
523 isomers, Delta 8 tetrahydrocannabinols and their optical
524 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
525 isomers, or any compound containing a tetrahydrobenzo[c]chromene
526 structure with substitution at either or both the 3-position or
527 9-position, with or without substitution at the 1-position with
528 hydroxyl or alkoxy groups, including, but not limited to:
529 (I) Tetrahydrocannabinol.
530 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
531 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
532 ol).
533 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
534 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
535 ol).
536 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
537 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
538 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
539 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
540 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
541 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
542 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
543 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
544 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
545 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
546 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
547 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
548 (X) Parahexyl.
549 b. Naphthoylindoles, Naphthoylindazoles,
550 Naphthoylcarbazoles, Naphthylmethylindoles,
551 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
552 compound containing a naphthoylindole, naphthoylindazole,
553 naphthoylcarbazole, naphthylmethylindole,
554 naphthylmethylindazole, or naphthylmethylcarbazole structure,
555 with or without substitution on the indole, indazole, or
556 carbazole ring to any extent, whether or not substituted on the
557 naphthyl ring to any extent, including, but not limited to:
558 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
559 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
560 naphthoyl)indole).
561 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
562 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
563 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
564 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
565 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
566 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
567 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
568 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
569 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
570 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
571 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
572 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
573 naphthoyl)indole).
574 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
575 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
576 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
577 naphthoyl)indole).
578 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
579 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
580 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
581 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
582 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
583 naphthylmethyl]indole).
584 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
585 naphthoyl)indole).
586 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
587 naphthoyl)indole).
588 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
589 naphthoyl)indole).
590 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
591 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
592 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
593 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
594 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
595 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
596 naphthoyl)indole).
597 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
598 naphthoyl)indole).
599 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
600 naphthoyl)indole).
601 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
602 naphthoyl)indole).
603 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
604 naphthoyl)indole).
605 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
606 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
607 naphthoyl)indazole).
608 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
609 naphthoyl)indole).
610 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
611 naphthoyl)indole).
612 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
613 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
614 naphthoyl)carbazole).
615 c. Naphthoylpyrroles.—Any compound containing a
616 naphthoylpyrrole structure, with or without substitution on the
617 pyrrole ring to any extent, whether or not substituted on the
618 naphthyl ring to any extent, including, but not limited to:
619 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
620 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
621 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
622 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
623 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
624 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
625 naphthoyl)pyrrole).
626 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
627 naphthoyl)pyrrole).
628 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
629 naphthoyl)pyrrole).
630 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
631 naphthoyl)pyrrole).
632 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
633 naphthoyl)pyrrole).
634 d. Naphthylmethylenindenes.—Any compound containing a
635 naphthylmethylenindene structure, with or without substitution
636 at the 3-position of the indene ring to any extent, whether or
637 not substituted on the naphthyl ring to any extent, including,
638 but not limited to, JWH-176 (3-Pentyl-1
639 (naphthylmethylene)indene).
640 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
641 compound containing a phenylacetylindole or phenylacetylindazole
642 structure, with or without substitution on the indole or
643 indazole ring to any extent, whether or not substituted on the
644 phenyl ring to any extent, including, but not limited to:
645 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
646 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
647 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
648 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
649 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
650 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
651 (VII) Cannabipiperidiethanone.
652 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
653 methoxyphenylacetyl)indole).
654 f. Cyclohexylphenols.—Any compound containing a
655 cyclohexylphenol structure, with or without substitution at the
656 5-position of the phenolic ring to any extent, whether or not
657 substituted on the cyclohexyl ring to any extent, including, but
658 not limited to:
659 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
660 yl)phenol).
661 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
662 homologue).
663 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
664 methyloctan-2-yl)phenol).
665 g. Benzoylindoles and Benzoylindazoles.—Any compound
666 containing a benzoylindole or benzoylindazole structure, with or
667 without substitution on the indole or indazole ring to any
668 extent, whether or not substituted on the phenyl ring to any
669 extent, including, but not limited to:
670 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
671 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
672 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
673 iodo-5-nitrobenzoyl)indole).
674 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
675 methoxybenzoyl)indole).
676 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
677 iodobenzoyl)indole).
678 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
679 (VII) RCS-4 C4 homologue (1-Butyl-3-(4
680 methoxybenzoyl)indole).
681 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
682 3-(4-methoxybenzoyl)indole).
683 h. Tetramethylcyclopropanoylindoles and
684 Tetramethylcyclopropanoylindazoles.—Any compound containing a
685 tetramethylcyclopropanoylindole or
686 tetramethylcyclopropanoylindazole structure, with or without
687 substitution on the indole or indazole ring to any extent,
688 whether or not substituted on the tetramethylcyclopropyl group
689 to any extent, including, but not limited to:
690 (I) UR-144 (1-Pentyl-3-(2,2,3,3
691 tetramethylcyclopropanoyl)indole).
692 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
693 tetramethylcyclopropanoyl)indole).
694 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
695 tetramethylcyclopropanoyl)indole).
696 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
697 tetramethylcyclopropanoyl)indole).
698 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
699 tetramethylcyclopropanoyl)indole).
700 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
701 tetramethylcyclopropanoyl)indole).
702 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
703 tetramethylcyclopropanoyl)indole).
704 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
705 tetramethylcyclopropanoyl)indazole).
706 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
707 tetramethylcyclopropanoyl)indole).
708 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
709 tetramethylcyclopropanoyl)indole).
710 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
711 carboxamides, and Adamantylindazole carboxamides.—Any compound
712 containing an adamantoyl indole, adamantoyl indazole, adamantyl
713 indole carboxamide, or adamantyl indazole carboxamide structure,
714 with or without substitution on the indole or indazole ring to
715 any extent, whether or not substituted on the adamantyl ring to
716 any extent, including, but not limited to:
717 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
718 (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
719 3-carboxamide).
720 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
721 carboxamide).
722 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
723 adamantoyl)indole).
724 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
725 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
726 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
727 adamantoyl)indole).
728 j. Quinolinylindolecarboxylates,
729 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
730 and Quinolinylindazolecarboxamides.—Any compound containing a
731 quinolinylindole carboxylate, quinolinylindazole carboxylate,
732 isoquinolinylindole carboxylate, isoquinolinylindazole
733 carboxylate, quinolinylindole carboxamide, quinolinylindazole
734 carboxamide, isoquinolinylindole carboxamide, or
735 isoquinolinylindazole carboxamide structure, with or without
736 substitution on the indole or indazole ring to any extent,
737 whether or not substituted on the quinoline or isoquinoline ring
738 to any extent, including, but not limited to:
739 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
740 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
741 carboxylate).
742 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
743 carboxylate).
744 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
745 carboxylate).
746 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
747 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
748 3-carboxylate).
749 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
750 3-carboxylate).
751 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
752 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
753 carboxamide).
754 k. Naphthylindolecarboxylates and
755 Naphthylindazolecarboxylates.—Any compound containing a
756 naphthylindole carboxylate or naphthylindazole carboxylate
757 structure, with or without substitution on the indole or
758 indazole ring to any extent, whether or not substituted on the
759 naphthyl ring to any extent, including, but not limited to:
760 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
761 carboxylate).
762 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
763 carboxylate).
764 (III) Fluoro SDB-005 (1-Naphthalenyl 1
765 (fluoropentyl)indazole-3-carboxylate).
766 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
767 carboxylate).
768 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
769 carboxylate).
770 l. Naphthylindole carboxamides and Naphthylindazole
771 carboxamides.—Any compound containing a naphthylindole
772 carboxamide or naphthylindazole carboxamide structure, with or
773 without substitution on the indole or indazole ring to any
774 extent, whether or not substituted on the naphthyl ring to any
775 extent, including, but not limited to:
776 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
777 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
778 3-carboxamide).
779 (III) Chloro-NNEI (N-Naphthalen-1-yl 1
780 (chloropentyl)indole-3-carboxamide).
781 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
782 carboxamide).
783 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
784 (fluoropentyl)indazole-3-carboxamide).
785 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
786 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
787 Alkylcarbonyl indazole carboxylates.—Any compound containing an
788 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
789 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
790 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
791 indole carboxamide, indazole carboxamide, indole carboxylate, or
792 indazole carboxylate, with or without substitution on the indole
793 or indazole ring to any extent, whether or not substituted on
794 the alkylcarbonyl group to any extent, including, but not
795 limited to:
796 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
797 pentylindole-3-carboxamide).
798 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
799 yl)-1-(fluoropentyl)indole-3-carboxamide).
800 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
801 (fluoropentyl)indole-3-carboxamide).
802 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
803 pentylindazole-3-carboxamide).
804 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
805 1-(fluoropentyl)indazole-3-carboxamide).
806 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
807 1-pentylindazole-3-carboxamide).
808 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
809 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
810 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
811 (4-fluorobenzyl)indazole-3-carboxamide).
812 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
813 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
814 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
815 (cyclohexylmethyl)indazole-3-carboxamide).
816 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
817 (cyclohexylmethyl)indazole-3-carboxamide).
818 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
819 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
820 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
821 pentylindazole-3-carboxamide).
822 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
823 (fluoropentyl)indazole-3-carboxamide).
824 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
825 fluorobenzyl)indazole-3-carboxamide).
826 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
827 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
828 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
829 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
830 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
831 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
832 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
833 fluoropentyl)indole-3-carboxamide).
834 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
835 fluoropentyl)indazole-3-carboxamide).
836 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
837 (cyclohexylmethyl)indazole-3-carboxamide).
838 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
839 fluorobenzyl)indazole-3-carboxamide).
840 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
841 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
842 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
843 Any compound containing a N-(2-phenylpropan-2-yl) indole
844 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
845 structure, with or without substitution on the indole or
846 indazole ring to any extent, whether or not substituted on the
847 phenyl ring of the cumyl group to any extent, including, but not
848 limited to:
849 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
850 carboxamide).
851 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
852 (fluoropentyl)indole-3-carboxamide).
853 o. Other Synthetic Cannabinoids.—Any material, compound,
854 mixture, or preparation that contains any quantity of a
855 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
856 (I) With or without modification or replacement of a
857 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
858 between either two core rings, or linkage between a core ring
859 and group structure, with or without the addition of a carbon or
860 replacement of a carbon;
861 (II) With or without replacement of a core ring or group
862 structure, whether or not substituted on the ring or group
863 structures to any extent; and
864 (III) Is a cannabinoid receptor agonist, unless
865 specifically excepted or unless listed in another schedule or
866 contained within a pharmaceutical product approved by the United
867 States Food and Drug Administration.
868 191. Substituted Cathinones.—Unless specifically excepted,
869 listed in another schedule, or contained within a pharmaceutical
870 product approved by the United States Food and Drug
871 Administration, any material, compound, mixture, or preparation,
872 including its salts, isomers, esters, or ethers, and salts of
873 isomers, esters, or ethers, whenever the existence of such salts
874 is possible within any of the following specific chemical
875 designations:
876 a. Any compound containing a 2-amino-1-phenyl-1-propanone
877 structure;
878 b. Any compound containing a 2-amino-1-naphthyl-1-propanone
879 structure; or
880 c. Any compound containing a 2-amino-1-thiophenyl-1
881 propanone structure,
882
883 whether or not the compound is further modified:
884 (I) With or without substitution on the ring system to any
885 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
886 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
887 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
888 substituents;
889 (II) With or without substitution at the 3-propanone
890 position with an alkyl substituent or removal of the methyl
891 group at the 3-propanone position;
892 (III) With or without substitution at the 2-amino nitrogen
893 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
894 not further substituted in the ring system; or
895 (IV) With or without inclusion of the 2-amino nitrogen atom
896 in a cyclic structure, including, but not limited to:
897 (A) Methcathinone.
898 (B) Ethcathinone.
899 (C) Methylone (3,4-Methylenedioxymethcathinone).
900 (D) 2,3-Methylenedioxymethcathinone.
901 (E) MDPV (3,4-Methylenedioxypyrovalerone).
902 (F) Methylmethcathinone.
903 (G) Methoxymethcathinone.
904 (H) Fluoromethcathinone.
905 (I) Methylethcathinone.
906 (J) Butylone (3,4-Methylenedioxy-alpha
907 methylaminobutyrophenone).
908 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
909 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
910 (M) Naphyrone (Naphthylpyrovalerone).
911 (N) Bromomethcathinone.
912 (O) Buphedrone (alpha-Methylaminobutyrophenone).
913 (P) Eutylone (3,4-Methylenedioxy-alpha
914 ethylaminobutyrophenone).
915 (Q) Dimethylcathinone.
916 (R) Dimethylmethcathinone.
917 (S) Pentylone (3,4-Methylenedioxy-alpha
918 methylaminovalerophenone).
919 (T) Pentedrone (alpha-Methylaminovalerophenone).
920 (U) MDPPP (3,4-Methylenedioxy-alpha
921 pyrrolidinopropiophenone).
922 (V) MDPBP (3,4-Methylenedioxy-alpha
923 pyrrolidinobutyrophenone).
924 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
925 (X) PPP (Pyrrolidinopropiophenone).
926 (Y) PVP (Pyrrolidinovalerophenone) or
927 (Pyrrolidinopentiophenone).
928 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
929 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
930 (BB) F-MABP (Fluoromethylaminobutyrophenone).
931 (CC) Me-EABP (Methylethylaminobutyrophenone).
932 (DD) PBP (Pyrrolidinobutyrophenone).
933 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
934 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
935 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
936 (HH) Dimethylone (3,4-Methylenedioxy-N,N
937 dimethylcathinone).
938 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
939 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
940 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
941 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
942 (MM) Methylbuphedrone (Methyl-alpha
943 methylaminobutyrophenone).
944 (NN) Methyl-alpha-methylaminohexanophenone.
945 (OO) N-Ethyl-N-methylcathinone.
946 (PP) PHP (Pyrrolidinohexanophenone).
947 (QQ) PV8 (Pyrrolidinoheptanophenone).
948 (RR) Chloromethcathinone.
949 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
950 192. Substituted Phenethylamines.—Unless specifically
951 excepted or unless listed in another schedule, or contained
952 within a pharmaceutical product approved by the United States
953 Food and Drug Administration, any material, compound, mixture,
954 or preparation, including its salts, isomers, esters, or ethers,
955 and salts of isomers, esters, or ethers, whenever the existence
956 of such salts is possible within any of the following specific
957 chemical designations, any compound containing a phenethylamine
958 structure, without a beta-keto group, and without a benzyl group
959 attached to the amine group, whether or not the compound is
960 further modified with or without substitution on the phenyl ring
961 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
962 halide, fused alkylenedioxy, fused furan, fused benzofuran,
963 fused dihydrofuran, or fused tetrahydropyran substituents,
964 whether or not further substituted on a ring to any extent, with
965 or without substitution at the alpha or beta position by any
966 alkyl substituent, with or without substitution at the nitrogen
967 atom, and with or without inclusion of the 2-amino nitrogen atom
968 in a cyclic structure, including, but not limited to:
969 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
970 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
971 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
972 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
973 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
974 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
975 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
976 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
977 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
978 j. 2C-H (2,5-Dimethoxyphenethylamine).
979 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
980 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
981 m. MDMA (3,4-Methylenedioxymethamphetamine).
982 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
983 Methylenedioxy-N-methylbutanamine).
984 o. MDA (3,4-Methylenedioxyamphetamine).
985 p. 2,5-Dimethoxyamphetamine.
986 q. Fluoroamphetamine.
987 r. Fluoromethamphetamine.
988 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
989 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
990 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
991 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
992 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
993 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
994 y. PMA (4-Methoxyamphetamine).
995 z. N-Ethylamphetamine.
996 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
997 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
998 cc. PMMA (4-Methoxymethamphetamine).
999 dd. N,N-Dimethylamphetamine.
1000 ee. 3,4,5-Trimethoxyamphetamine.
1001 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
1002 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
1003 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
1004 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
1005 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1006 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1007 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1008 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1009 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
1010 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
1011 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
1012 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
1013 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
1014 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
1015 dihydrobenzofuran),
1016
1017 which does not include phenethylamine, mescaline as described in
1018 subparagraph 20., substituted cathinones as described in
1019 subparagraph 191., N-Benzyl phenethylamine compounds as
1020 described in subparagraph 193., or methamphetamine as described
1021 in subparagraph (2)(c)5.
1022 193. N-Benzyl Phenethylamine Compounds.—Unless specifically
1023 excepted or unless listed in another schedule, or contained
1024 within a pharmaceutical product approved by the United States
1025 Food and Drug Administration, any material, compound, mixture,
1026 or preparation, including its salts, isomers, esters, or ethers,
1027 and salts of isomers, esters, or ethers, whenever the existence
1028 of such salts is possible within any of the following specific
1029 chemical designations, any compound containing a phenethylamine
1030 structure without a beta-keto group, with substitution on the
1031 nitrogen atom of the amino group with a benzyl substituent, with
1032 or without substitution on the phenyl or benzyl ring to any
1033 extent with alkyl, alkoxy, thio, alkylthio, halide, fused
1034 alkylenedioxy, fused furan, fused benzofuran, or fused
1035 tetrahydropyran substituents, whether or not further substituted
1036 on a ring to any extent, with or without substitution at the
1037 alpha position by any alkyl substituent, including, but not
1038 limited to:
1039 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
1040 methoxybenzyl)]phenethylamine).
1041 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
1042 hydroxybenzyl)]phenethylamine).
1043 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
1044 fluorobenzyl)]phenethylamine).
1045 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
1046 methylenedioxybenzyl)]phenethylamine).
1047 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
1048 methoxybenzyl)]phenethylamine).
1049 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
1050 hydroxybenzyl)]phenethylamine).
1051 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
1052 fluorobenzyl)]phenethylamine).
1053 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
1054 methylenedioxybenzyl)]phenethylamine).
1055 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
1056 methoxybenzyl)]phenethylamine).
1057 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
1058 methoxybenzyl)]phenethylamine).
1059 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
1060 methoxybenzyl)]phenethylamine).
1061 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
1062 methoxybenzyl)]phenethylamine).
1063 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
1064 hydroxybenzyl)]phenethylamine).
1065 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
1066 fluorobenzyl)]phenethylamine).
1067 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
1068 methylenedioxybenzyl)]phenethylamine).
1069 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
1070 methoxybenzyl)]phenethylamine).
1071 q. 25H-NBOH (2,5-Dimethoxy-[N-(2
1072 hydroxybenzyl)]phenethylamine).
1073 r. 25H-NBF (2,5-Dimethoxy-[N-(2
1074 fluorobenzyl)]phenethylamine).
1075 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
1076 methoxybenzyl)]phenethylamine),
1077
1078 which does not include substituted cathinones as described in
1079 subparagraph 191.
1080 194. Substituted Tryptamines.—Unless specifically excepted
1081 or unless listed in another schedule, or contained within a
1082 pharmaceutical product approved by the United States Food and
1083 Drug Administration, any material, compound, mixture, or
1084 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
1085 example tryptamine, structure with or without mono- or di
1086 substitution of the amine nitrogen with alkyl or alkenyl groups,
1087 or by inclusion of the amino nitrogen atom in a cyclic
1088 structure, whether or not substituted at the alpha position with
1089 an alkyl group, whether or not substituted on the indole ring to
1090 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
1091 groups, including, but not limited to:
1092 a. Alpha-Ethyltryptamine.
1093 b. Bufotenine.
1094 c. DET (Diethyltryptamine).
1095 d. DMT (Dimethyltryptamine).
1096 e. MET (N-Methyl-N-ethyltryptamine).
1097 f. DALT (N,N-Diallyltryptamine).
1098 g. EiPT (N-Ethyl-N-isopropyltryptamine).
1099 h. MiPT (N-Methyl-N-isopropyltryptamine).
1100 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
1101 j. 5-Hydroxy-N-methyltryptamine.
1102 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
1103 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
1104 m. Methyltryptamine.
1105 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
1106 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
1107 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
1108 q. DiPT (N,N-Diisopropyltryptamine).
1109 r. DPT (N,N-Dipropyltryptamine).
1110 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
1111 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
1112 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
1113 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
1114 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
1115 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
1116 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
1117 isopropyltryptamine).
1118 z. Methyl-alpha-ethyltryptamine.
1119 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
1120
1121 which does not include tryptamine, psilocyn as described in
1122 subparagraph 34., or psilocybin as described in subparagraph 33.
1123 195. Substituted Phenylcyclohexylamines.—Unless
1124 specifically excepted or unless listed in another schedule, or
1125 contained within a pharmaceutical product approved by the United
1126 States Food and Drug Administration, any material, compound,
1127 mixture, or preparation containing a phenylcyclohexylamine
1128 structure, with or without any substitution on the phenyl ring,
1129 any substitution on the cyclohexyl ring, any replacement of the
1130 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
1131 without substitution on the amine with alkyl, dialkyl, or alkoxy
1132 substituents, inclusion of the nitrogen in a cyclic structure,
1133 or any combination of the above, including, but not limited to:
1134 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
1135 (Benocyclidine).
1136 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
1137 of phencyclidine).
1138 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
1139 analog of phencyclidine).
1140 d. PCPr (Phenylcyclohexylpropylamine).
1141 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
1142 analog of phencyclidine).
1143 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
1144 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
1145 h. Methoxetamine.
1146 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
1147 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
1148 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
1149 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
1150 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
1151 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
1152 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
1153 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
1154 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
1155 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
1156 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
1157 piperidinylidene]-benzenesulfonamide.
1158 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
1159 piperidinylidene]-benzenesulfonamide.
1160 198. AH-7921, 3,4-dichloro-N-[[1
1161 (dimethylamino)cyclohexyl]methyl]-benzamide.
1162 199. U47700, trans-3,4-dichloro-N-[2
1163 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
1164 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
1165 dihydrochloride.
1166 Section 2. Paragraph (i) of subsection (1) of section
1167 893.13, Florida Statutes, is amended to read:
1168 893.13 Prohibited acts; penalties.—
1169 (1)
1170 (i) Except as authorized by this chapter, a person commits
1171 a felony of the first degree, punishable as provided in s.
1172 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1173 mandatory minimum term of imprisonment of 3 years, if:
1174 1. The person sells, manufactures, or delivers, or
1175 possesses with intent to sell, manufacture, or deliver, any of
1176 the following:
1177 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1178 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1179 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1180 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1181 e. A fentanyl derivative, as described in s.
1182 893.03(1)(a)63.;
1183 f. Xylazine, as described in s. 893.03(1)(c)37.;
1184 g. A controlled substance analog, as described in s.
1185 893.0356, of any substance described in sub-subparagraphs a.-f.
1186 a.-e.; or
1187 h.g. A mixture containing any substance described in sub
1188 subparagraphs a.-g. a.-f.; and
1189 2. The substance or mixture listed in subparagraph 1. is in
1190 a form that resembles, or is mixed, granulated, absorbed, spray
1191 dried, or aerosolized as or onto, coated on, in whole or in
1192 part, or solubilized with or into, a product, when such product
1193 or its packaging further has at least one of the following
1194 attributes:
1195 a. Resembles the trade dress of a branded food product,
1196 consumer food product, or logo food product;
1197 b. Incorporates an actual or fake registered copyright,
1198 service mark, or trademark;
1199 c. Resembles candy, cereal, a gummy, a vitamin, or a
1200 chewable product, such as a gum or gelatin-based product; or
1201 d. Contains a cartoon character imprint.
1202 Section 3. Paragraph (c) of subsection (1) of section
1203 893.135, Florida Statutes, is amended to read:
1204 893.135 Trafficking; mandatory sentences; suspension or
1205 reduction of sentences; conspiracy to engage in trafficking.—
1206 (1) Except as authorized in this chapter or in chapter 499
1207 and notwithstanding the provisions of s. 893.13:
1208 (c)1. A person who knowingly sells, purchases,
1209 manufactures, delivers, or brings into this state, or who is
1210 knowingly in actual or constructive possession of, 4 grams or
1211 more of any morphine, opium, hydromorphone, or any salt,
1212 derivative, isomer, or salt of an isomer thereof, including
1213 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
1214 (3)(c)4., or 4 grams or more of any mixture containing any such
1215 substance, but less than 30 kilograms of such substance or
1216 mixture, commits a felony of the first degree, which felony
1217 shall be known as “trafficking in illegal drugs,” punishable as
1218 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1219 quantity involved:
1220 a. Is 4 grams or more, but less than 14 grams, such person
1221 shall be sentenced to a mandatory minimum term of imprisonment
1222 of 3 years and shall be ordered to pay a fine of $50,000.
1223 b. Is 14 grams or more, but less than 28 grams, such person
1224 shall be sentenced to a mandatory minimum term of imprisonment
1225 of 15 years and shall be ordered to pay a fine of $100,000.
1226 c. Is 28 grams or more, but less than 30 kilograms, such
1227 person shall be sentenced to a mandatory minimum term of
1228 imprisonment of 25 years and shall be ordered to pay a fine of
1229 $500,000.
1230 2. A person who knowingly sells, purchases, manufactures,
1231 delivers, or brings into this state, or who is knowingly in
1232 actual or constructive possession of, 28 grams or more of
1233 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
1234 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
1235 grams or more of any mixture containing any such substance,
1236 commits a felony of the first degree, which felony shall be
1237 known as “trafficking in hydrocodone,” punishable as provided in
1238 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
1239 a. Is 28 grams or more, but less than 50 grams, such person
1240 shall be sentenced to a mandatory minimum term of imprisonment
1241 of 3 years and shall be ordered to pay a fine of $50,000.
1242 b. Is 50 grams or more, but less than 100 grams, such
1243 person shall be sentenced to a mandatory minimum term of
1244 imprisonment of 7 years and shall be ordered to pay a fine of
1245 $100,000.
1246 c. Is 100 grams or more, but less than 300 grams, such
1247 person shall be sentenced to a mandatory minimum term of
1248 imprisonment of 15 years and shall be ordered to pay a fine of
1249 $500,000.
1250 d. Is 300 grams or more, but less than 30 kilograms, such
1251 person shall be sentenced to a mandatory minimum term of
1252 imprisonment of 25 years and shall be ordered to pay a fine of
1253 $750,000.
1254 3. A person who knowingly sells, purchases, manufactures,
1255 delivers, or brings into this state, or who is knowingly in
1256 actual or constructive possession of, 7 grams or more of
1257 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1258 thereof, or 7 grams or more of any mixture containing any such
1259 substance, commits a felony of the first degree, which felony
1260 shall be known as “trafficking in oxycodone,” punishable as
1261 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1262 quantity involved:
1263 a. Is 7 grams or more, but less than 14 grams, such person
1264 shall be sentenced to a mandatory minimum term of imprisonment
1265 of 3 years and shall be ordered to pay a fine of $50,000.
1266 b. Is 14 grams or more, but less than 25 grams, such person
1267 shall be sentenced to a mandatory minimum term of imprisonment
1268 of 7 years and shall be ordered to pay a fine of $100,000.
1269 c. Is 25 grams or more, but less than 100 grams, such
1270 person shall be sentenced to a mandatory minimum term of
1271 imprisonment of 15 years and shall be ordered to pay a fine of
1272 $500,000.
1273 d. Is 100 grams or more, but less than 30 kilograms, such
1274 person shall be sentenced to a mandatory minimum term of
1275 imprisonment of 25 years and shall be ordered to pay a fine of
1276 $750,000.
1277 4.a. A person who knowingly sells, purchases, manufactures,
1278 delivers, or brings into this state, or who is knowingly in
1279 actual or constructive possession of, 4 grams or more of:
1280 (I) Alfentanil, as described in s. 893.03(2)(b)1.;
1281 (II) Carfentanil, as described in s. 893.03(2)(b)6.;
1282 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
1283 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
1284 (V) A fentanyl derivative, as described in s.
1285 893.03(1)(a)63.;
1286 (VI) A controlled substance analog, as described in s.
1287 893.0356, of any substance described in sub-sub-subparagraphs
1288 (I)-(V); or
1289 (VII) A mixture containing any substance described in sub
1290 sub-subparagraphs (I)-(VI),
1291
1292 commits a felony of the first degree, which felony shall be
1293 known as “trafficking in dangerous fentanyl or fentanyl
1294 analogues,” punishable as provided in s. 775.082, s. 775.083, or
1295 s. 775.084.
1296 b. If the quantity involved under sub-subparagraph a.:
1297 (I) Is 4 grams or more, but less than 14 grams, such person
1298 shall be sentenced to a mandatory minimum term of imprisonment
1299 of 7 years, and shall be ordered to pay a fine of $50,000.
1300 (II) Is 14 grams or more, but less than 28 grams, such
1301 person shall be sentenced to a mandatory minimum term of
1302 imprisonment of 20 years, and shall be ordered to pay a fine of
1303 $100,000.
1304 (III) Is 28 grams or more, such person shall be sentenced
1305 to a mandatory minimum term of imprisonment of 25 years, and
1306 shall be ordered to pay a fine of $500,000.
1307 c. A person 18 years of age or older who violates sub
1308 subparagraph a. by knowingly selling or delivering to a minor at
1309 least 4 grams of a substance or mixture listed in sub
1310 subparagraph a. shall be sentenced to a mandatory minimum term
1311 of not less than 25 years and not exceeding life imprisonment,
1312 and shall be ordered to pay a fine of $1 million if the
1313 substance or mixture listed in sub-subparagraph a. is in a form
1314 that resembles, or is mixed, granulated, absorbed, spray-dried,
1315 or aerosolized as or onto, coated on, in whole or in part, or
1316 solubilized with or into, a product, when such product or its
1317 packaging further has at least one of the following attributes:
1318 (I) Resembles the trade dress of a branded food product,
1319 consumer food product, or logo food product;
1320 (II) Incorporates an actual or fake registered copyright,
1321 service mark, or trademark;
1322 (III) Resembles candy, cereal, a gummy, a vitamin, or a
1323 chewable product, such as a gum or gelatin-based product; or
1324 (IV) Contains a cartoon character imprint.
1325 5. A person who knowingly sells, purchases, manufactures,
1326 delivers, or brings into this state, or who is knowingly in
1327 actual or constructive possession of, 30 kilograms or more of
1328 any morphine, opium, oxycodone, hydrocodone, codeine,
1329 hydromorphone, or any salt, derivative, isomer, or salt of an
1330 isomer thereof, including heroin, as described in s.
1331 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
1332 more of any mixture containing any such substance, commits the
1333 first degree felony of trafficking in illegal drugs. A person
1334 who has been convicted of the first degree felony of trafficking
1335 in illegal drugs under this subparagraph shall be punished by
1336 life imprisonment and is ineligible for any form of
1337 discretionary early release except pardon or executive clemency
1338 or conditional medical release under s. 947.149. However, if the
1339 court determines that, in addition to committing any act
1340 specified in this paragraph:
1341 a. The person intentionally killed an individual or
1342 counseled, commanded, induced, procured, or caused the
1343 intentional killing of an individual and such killing was the
1344 result; or
1345 b. The person’s conduct in committing that act led to a
1346 natural, though not inevitable, lethal result,
1347
1348 such person commits the capital felony of trafficking in illegal
1349 drugs, punishable as provided in ss. 775.082 and 921.142. A
1350 person sentenced for a capital felony under this paragraph shall
1351 also be sentenced to pay the maximum fine provided under
1352 subparagraph 1.
1353 6. A person who knowingly brings into this state 60
1354 kilograms or more of any morphine, opium, oxycodone,
1355 hydrocodone, codeine, hydromorphone, or any salt, derivative,
1356 isomer, or salt of an isomer thereof, including heroin, as
1357 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
1358 60 kilograms or more of any mixture containing any such
1359 substance, and who knows that the probable result of such
1360 importation would be the death of a person, commits capital
1361 importation of illegal drugs, a capital felony punishable as
1362 provided in ss. 775.082 and 921.142. A person sentenced for a
1363 capital felony under this paragraph shall also be sentenced to
1364 pay the maximum fine provided under subparagraph 1.
1365 7. A person who knowingly sells, purchases, manufactures,
1366 delivers, or brings into this state, or who is knowingly in
1367 actual or constructive possession of, 28 grams or more of
1368 xylazine as described in s. 893.03(1)(c)37. or any salt thereof,
1369 or 28 grams or more of any mixture containing any such
1370 substance, commits a felony of the first degree, which felony
1371 shall be known as “trafficking in xylazine,” punishable as
1372 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1373 quantity involved:
1374 a. Is 28 grams or more, but less than 100 grams, such
1375 person shall be sentenced to a mandatory minimum term of
1376 imprisonment of 3 years and shall be ordered to pay a fine of
1377 $100,000.
1378 b. Is 100 grams or more, but less than 200 grams, such
1379 person shall be sentenced to a mandatory minimum term of
1380 imprisonment of 7 years and shall be ordered to pay a fine of
1381 $100,000.
1382 c. Is 200 grams or more, such person shall be sentenced to
1383 a mandatory minimum term of imprisonment of 25 years and shall
1384 be ordered to pay a fine of $500,000.
1385 Section 4. Except as otherwise expressly provided in this
1386 act and except for this section, which shall take effect July 1,
1387 2026, this act shall take effect October 1, 2026.